NCT07472231

Brief Summary

This project addresses the challenge of visual function intervention in children with monocular anisometropic amblyopia. It employs two innovatively designed digital games combined with occlusion therapy to conduct visual function training through parent-child interaction in home or multi-scenario environments. The study will compare this combined approach against traditional occlusion therapy alone, evaluating improvements in visual function, intrinsic motivation, and emotion regulation before and after the intervention. The research aims to promote the implementation and dissemination of personalized and engaging healthcare services. Ultimately, it seeks to establish a comprehensive visual function training product and service system suitable for daily use in home settings, with the goals of reducing medical anxiety in children and holistically enhancing treatment efficacy, training compliance, and overall clinical experience.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
May 2026Dec 2026

First Submitted

Initial submission to the registry

December 4, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 16, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 30, 2026

Status Verified

April 1, 2026

Enrollment Period

7 months

First QC Date

December 4, 2025

Last Update Submit

July 29, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of participants with Objective improvement in visual function

    Contrast sensitivity measured using the standard contrast sensitivity test;Stereopsis measured using the Titmus Fly Test;Simultaneous perception assessed using the Worth 4-dot test;Fusion ability assessed using the synoptophore with line fusion targets.

    3 months after the first visit

  • Best-Corrected Visual Acuity (BCVA) assessed by LogMAR chart

    3 months after the first visit

Secondary Outcomes (5)

  • Improvement in functional vision in daily living

    3 months after the first visit

  • Medical fear assessed by Child Medical Fear Scale (CMFS)

    3 months after the first visit

  • Anxiety assessed by Child Anxiety Meter-State (CAM-S)

    3 months after the first visit

  • Compliance

    3 months after the first visit

  • Acceptance

    3 months after the first visit

Study Arms (3)

Group 1 (Intervention)

EXPERIMENTAL

Serious touchscreen game combined with occlusion

Device: Serious touchscreen game combined with occlusion

Group 2 (Intervention)

EXPERIMENTAL

Augmented Reality game combined with occlusion

Device: Augmented reality game combined with occlusion

Control Group

ACTIVE COMPARATOR

Occlusion therapy only

Behavioral: Occlusion therapy

Interventions

The game designed for amblyopia training feature innovative designs.

Group 1 (Intervention)

Wear an eye patch on the sound eye side daily for 4 hours.

Control Group

The game designed for amblyopia training feature innovative designs.

Group 2 (Intervention)

Eligibility Criteria

Age4 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Clinically diagnosed with monocular anisometropic amblyopia.
  • Aged 4 to 7 years.
  • Able to cooperate with all examinations and comply with the amblyopia training regimen.
  • Provided signed informed consent.

You may not qualify if:

  • Severe developmental delay or cognitive impairment.
  • Serious systemic diseases.
  • Presence of organic ocular diseases (e.g., cataract, fundus diseases) or manifest strabismus.
  • Participation in any other eye-related interventional trial within the past 4 weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200092, China

RECRUITING

MeSH Terms

Conditions

Amblyopia

Interventions

Dental Occlusion

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

DentistryDental Physiological PhenomenaDigestive System and Oral Physiological Phenomena

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Physician of the Department of Ophthalmology

Study Record Dates

First Submitted

December 4, 2025

First Posted

March 16, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Due to participant privacy considerations and the terms of the ethical approval and informed consent documents for this study, individual participant data will not be publicly shared. Aggregated data and study results will be disseminated through academic publications.

Locations